What the research shows To explore whether GLP-1 medications are associated with increased risk of gastrointestinal conditions, a recent study compared over 200,000 individuals taking GLP-1 medications with a group taking other type 2 diabetes medications (1)
Boxed warning: Risk of thyroid cancer Zepbound has a boxed warning for the risk of thyroid cancer
L-carnitine is basically the low-key conveyor belt sending your fat to the incinerator
GLP-1 receptor agonists stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and act on central nervous system pathways to reduce appetite and food intake
Think of it as cellular therapy in a capsulesupporting detoxification, boosting resilience, and helping you reclaim your energy, clarity, and glow without overwhelming your system